HGWM
CORT icon

Harvest Group Wealth Management’s Corcept Therapeutics CORT Stock Holding History

Harvest Group Wealth Management’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-14
Closed – – 170
2020
Q4 		$0 Hold
14
– – ﹤0.01% 675
2020
Q3 		$0 Hold
14
– – ﹤0.01% 622
2020
Q2 		$0 Hold
14
– – ﹤0.01% 546
2020
Q1 		$0 Sell
14
-130
-90% -$1.61K ﹤0.01% 584
2019
Q4 		$1K Hold
144
– – ﹤0.01% 740
2019
Q3 		$2K Hold
144
– – ﹤0.01% 666
2019
Q2 		$1K Buy
144
+19
+15% +$212 ﹤0.01% 686
2019
Q1 		$1K Buy
+125
New +$1.55K ﹤0.01% 749

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Harvest Group Wealth Management's CORT Position: Q1 2021 in Review

Harvest Group Wealth Management sold out of Corcept Therapeutics (CORT) in Q1 2021, closing a stake of 14 shares.

Harvest Group Wealth Management first reported a position in CORT in Q1 2019 and held it in 8 quarters. The position peaked at $2K in Q3 2019. 209 funds tracked by Wall St. Rank hold CORT as of Q1 2021.

  • Harvest Group Wealth Management reported no remaining Corcept Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Harvest Group Wealth Management sold 14 Corcept Therapeutics shares in Q1 2021.
  • Harvest Group Wealth Management first reported a position in Corcept Therapeutics in Q1 2019 and held it in 8 quarters.
  • Harvest Group Wealth Management's Corcept Therapeutics position peaked at $2K in Q3 2019.
  • 209 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2021.

Based on Harvest Group Wealth Management's 13F filing for Q1 2021, filed 4 May 2021.